Substitution of glycine-661 by serine in the α1(I) and α2(I) chains of type I collagen results in different clinical and biochemical phenotypes

Human Genetics

Volumn 97, Issue 3, 1996, Pages 324-329

  Nuytinck, Lieve ^a   Dalgleish, Raymond ^b   Spotila, Loretta ^c   Renard, Jean Pierre ^a   Van Regemorter, Nicole ^d   De Paepe, Anne ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; GLYCINE; SERINE;

ADULT; ALPHA CHAIN; AMINO ACID SUBSTITUTION; ARTICLE; BIOCHEMISTRY; CASE REPORT; CONTROLLED STUDY; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; INFANT; MALE; OSTEOGENESIS IMPERFECTA; PHENOTYPE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; THERMOSTABILITY;

EID: 0030059553     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02185764     Document Type: Article

References (26)

1. Bächinger HP, Davis JM (1991) Sequence specific thermal stability of the collagen triple helix. Int J Biol Macromol 13: 152-156
2. Bächinger HP, Morris NP, Davis JM (1993) Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. Am J Med Genet 45:152-162
3. Bateman JF, Lamande SR, Dahl H-HM, Chan D, Cole WG (1988) Substitution of arginine for glycine 667 in the collagen α1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA. J Biol Chem 263:11627-11630
4. Bateman JF, Moeller I, Hannagan M, Chan D, Cole WG (1992) Characterisation of three osteogenesis imperfecia collagen α1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severity. Biochem J 288: 131-135
5. Bonadio J, Holbrook HA, Gelinas RE, Jacobs J, Byers PH (1985) Altered triple helical structure of type I procollagen in lethal perinatal osteosenesis imperfecta. J Biol Chem 260: 1734-1742
6. Bruckner P, Prockop DJ (1981) Proteolytic enzymes as probes for the triple-helical conformation of procollagen. Anal Biochem 110:360-368
7. Byers PH (1993) Osteogenesis imperfecta. In: Royce PM, Steinmann B (eds) Connective tissue and its heritable disorders: molecular, genetic and medical aspects. Wiley-Liss, New York, pp 317-350
8. Cole WG, Chan D (1981) Analysis of the heterogeneity of human collagens by two-dimensional polyacrylamide gel electrophoresis. Biochem J 197:377-383
9. Gomez Lira M, Mottes M, Zolezzi F, Cohen-Solal L, Valli M, Pignatti PF (1993) CCM analysis of collagen type I mutations in very severe and lethal OI (abstract). Fifth International Conference on Osteogenesis Imperfecta, 1993, Oxford, UK
10. Kuivaniemi H, Tromp G, Prockop DJ (1991) Mutations in collagen genes: causes of rare and some common diseases in humans. FASEB J 5: 2052-2060
11. Mackay K, Byers PH, Dalgleish R (1993a) An RT-PCR-SSCP strategy for detection of mutations in the gene encoding the α1 chain of type I collagen: application to four patients with osteogenesis imperfecta. Hum Mol Genet 2: 1155-1160
12. Mackay K, Lund AM, Raghunath M, Steinmann B, Dalgleish R (1993b) SSCP detection of a Gly565Val substitution in the proα1(I) collagen chain resulting in osteogenesis imperfecta type II. Hum Genet 91:439-444
13. Marini JC, Lewis MB, Wang Q, Chen KJ, Orrison BM (1993) Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology. J Biol Chem 268: 2667-2673
14. Mottes M, Gomez Lira MM, Valli M, Scarano G, Lonardo F, Forlino A, Cetta G, Pignatti PF (1993) Paternal mosaicism for a COL1A1 dominant mutation (α1 Ser-415) causes recurrent osteogenesis imperfecta. Hum Mutat 2: 196-204
15. Nuytinck L, Narcisi P, Nicholls A, Renard JP, Pope FM, De Paepe A (1992) Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV. J Med Genet 29: 375-380
16. Raghunath M, Mackay K, Dalgleish R, Steinmann B (1995) Genetic counselling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation. Eur J Pediatr 154: 123-129
17. Rose NJ, Mackay K, Byers PH, Dalgleish R (1994a) A Gly859Ser substitution in the triple helical domain of the α2 chain of type I collagen resulting in osteogenesis imperfecta type III in two unrelated individuals. Hum Mutat 3: 391-394
18. Rose NJ, Mackay K, De Paepe A, Steinmann B, Punnett HH, Dalgleish R (1994b) Three unrelated individuals with permatally lethal Osteogenesis imperfecta resulting from identical Gly502-Ser substitutions in the α2-chain of type I collagen. Hum Genet 94:497-503
19. Privalov PL (1982) Stability of proteins. Adv Protein Chem 35: 1-104
20. Pruchno CJ, Conn DH, Wallis GA, Willing MC, Starman BJ, Zhang X, Byers PH (1991) Osteogenesis imperfecta due to recurrent point mutations at CpG dinucleotides in the COL1A1 gene of type I collagen. Hum Genet 87:33-40
21. Spotila LD, Constantinou CD, Sereda L, Ganguly A, Riggs BL, Prockop DJ (1991) Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Proc Natl Acad Sci USA 88:5423-5427
22. Spotila LD, Sereda L, Prockop DJ (1992) Partial isodisomy for maternal chromosome 7 and short stature in an individual with a mutation at the COL1A2 locus. Am J Hum Genet 51: 1396-1405
23. Tsuneyoshi T, Westerhausen A, Constantinou CD, Prockop DJ (1991) Substitutions for glycine α1-637 and glycine α2-694 of type I collagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix. J Biol Chem 266: 15608-15613
24. Wang Q, Orrison BM, Marini JC (1993) Two additional cases of osteogenesis imperfecta with substitutions for glycine in the α2(I) collagen chain. A regional model relating mutation location with phenotype. J Biol Chem 268:25162-25167
25. Wenstrup RJ, Shrago-Howe AW, Lever LW. Phillips CL, Byers PH, Cohn DH (1991) The effects of different cysteine for glycine substitutions within α2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix. J Biol Chem 266:2590-2594
26. Westerhausen A, Kishi J, Prockop DJ (1990) Mutations that substitute serine for glycine α1-598 and glycine α1-631 in type I procollagen. The effects on thermal unfolding of the triple helix are position-specific and demonstrate that the protein unfolds through a series of cooperative blocks. J Biol Chem 265: 13995-14012